Hobart Laboratories specializes in the development and manufacturing of Numotizine®, a topical analgesic product initially created in 1905 for the treatment of pneumonia. Over the years, Numotizine® has evolved into a versatile poultice widely used in both human and veterinary applications. The product is particularly effective for alleviating muscle soreness, stiffness, and pain in horses, making it a trusted choice among veterinarians, trainers, and pet owners. Its formulation includes active ingredients such as guaiacol and methyl guaiacol, which provide soothing relief and comfort for various muscular injuries, sprains, and bruises.

In addition to its primary use for horses, Numotizine® has been adapted for other animals, including livestock and dogs, showcasing its broad applicability in animal care. The poultice is designed for easy application, providing a protective barrier while delivering therapeutic benefits. Users have reported significant relief from symptoms such as lameness, swelling, and stiffness, reinforcing the product's reputation in the veterinary community. With a history of over 50 years in the market, Numotizine® continues to gain popularity through positive testimonials and word-of-mouth recommendations, highlighting its effectiveness and reliability in treating various animal ailments.

United States

Numotizine is a healthcare company that specializes in producing a patented poultice for external medical use.

Hobart Laboratories

Company Details